טוען...
Innovative approaches to clinical development and trial design
Pharmaceutical innovation is increasingly risky, costly and at times inefficient, which has led to a decline in industry productivity. Despite the increased investment in R&D by the industry, the number of new molecular entities achieving marketing authorization is not increasing. Novel approach...
שמור ב:
Main Authors: | , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Istituto Superiore di Sanità
2011-01-01
|
סדרה: | Annali dell'Istituto Superiore di Sanità |
נושאים: | |
גישה מקוונת: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0021-25712011000100003&lng=en&tlng=en |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|